Publications

Journal Article
Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.
Ppublish 377 citations
Open access — free full text available
Open access
Electronic publication date
April 26, 2002

View on Pubmed.gov 11830488 | View on doi.org 10.1182/blood.v... | View the free full text Full text

In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.

Search for publications in this journal Blood - 99(4):1364-72

Abstract

Familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML) is an autosomal dominant familial platelet disorder characterized by thrombocytopenia and a propensity to develop AML. Mutation analyses of RUNX1 in 3 families with FPD/AML showing linkage to chromosome 21q22.1 revealed 3 novel heterozygous point mutations (K83E, R135fsX177 (IVS4 + 3delA), and Y260X). Functional investigations of the 7 FPD/AML RUNX1 Runt domain point mutations described to date (2 frameshift, 2 nonsense, and 3 missense mutations) were performed. Consistent with the position of the mutations in the Runt domain at the RUNX1-DNA interface, DNA binding of all mutant RUNX1 proteins was absent or significantly decreased. In general, missense and nonsense RUNX1 proteins retained the ability to heterodimerize with PEBP2beta/CBFbeta and inhibited transactivation of a reporter gene by wild-type RUNX1. Colocalization of mutant RUNX1 and PEBP2beta/CBFbeta in the cytoplasm was observed. These results suggest that the sequestration of PEBP2beta/CBFbeta by mutant RUNX1 may cause the inhibitory effects. While haploinsufficiency of RUNX1 causes FPD/AML in some families (deletions and frameshifts), mutant RUNX1 proteins (missense and nonsense) may also inhibit wild-type RUNX1, possibly creating a higher propensity to develop leukemia. This is consistent with the hypothesis that a second mutation has to occur, either in RUNX1 or another gene, to cause leukemia among individuals harboring RUNX1 FPD/AML mutations and that the propensity to acquire these additional mutations is determined, at least partially, by the initial RUNX1 mutation.

References

No references provided.

Cited by 377 citations (total)

Journal Article

The MI bundle: enabling network and structural biology in genome visualization tools.

Electronic publication date May 31, 2016

Search for publications in this journal Bioinformatics

Arnaud Céol [...] Heiko Müller et al.

UNLABELLED

Prioritization of candidate genes emanating from large-scale screens requires integrated analyses at the genomics, molecular, network and structural biology levels....

Case Reports Journal Article

Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy.

Electronic publication date April 6, 2017

Search for publications in this journal Am J Clin Pathol

Chi Young Ok [...] Sergej Konoplev et al.

OBJECTIVES

To report aberrant myeloblasts detected by flow cytometry immunophenotypic studies in an asymptomatic patient with familial platelet disorder with propensity...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances